PPARGC1A and ischemia: In addition, the described results confirm that high dose of RWPC reduces neovascularisation in mice subjected to hindlimb ischemia via inhibition of NO pathway despite their ability to increase Sirt-1, AMPKα and PGC-1α/β expressions.